InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,726.31
(
-0.04%
)
US TECH 100
19,392.00
(
-0.54%
)
Dow Jones
41,908.29
(
-0.34%
)
Brent Oil
74.81
(
0.99%
)
Bitcoin
68,272.34
(
-0.68%
)
Post# of 253518
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120661
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 115541

Saturday, 02/26/2011 2:19:15 PM

Saturday, February 26, 2011 2:19:15 PM

Post# of 253518

PLX—Their cheap/high capacity technology could be a plus too though to me that isn't enough by itself unless their goal is to be a high-end "generics" play.

I think it’s important to distinguish between biosimilars and biogenerics. A low-cost manufacturing platform helps with the former, but it does not necessarily help with the latter.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up